Lysophosphatidic acid receptor 5 (LPAR5) overexpression is involved in mediating thyroid cancer progression; however, the mechanism underlying this process requires further elucidation (69, 70). This evidence concerns the gene LPAR5 and thyroid gland carcinoma.